GAI
MRVI icon

General American Investors’s Maravai LifeSciences MRVI Stock Holding History

General American Investors’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.86M Buy
1,716,193
+130,877
+8% +$444K 0.32% 57
2025
Q4 		$5.15M Buy
1,585,316
+1,448,907
+1,062% +$4.88M 0.29% 64
2025
Q3 		$391K Buy
+136,409
New +$348K 0.02% 74

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

General American Investors's MRVI Position: Q1 2026 in Review

General American Investors increased its Maravai LifeSciences (MRVI) stake by 8.3% in Q1 2026, buying an estimated $444K and bringing the position to 1,716,193 shares worth $4.86M. The position accounts for 0.32% of the portfolio, ranked #57.

General American Investors first reported a position in MRVI in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.15M in Q4 2025. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • General American Investors held 1,716,193 shares of Maravai LifeSciences worth $4.86M as of Q1 2026.
  • General American Investors bought 130,877 Maravai LifeSciences shares in Q1 2026, an estimated $444K.
  • Maravai LifeSciences made up 0.32% of General American Investors's portfolio in Q1 2026, its #57 holding.
  • General American Investors first reported a position in Maravai LifeSciences in Q3 2025 and has held it in 3 quarters since.
  • General American Investors's Maravai LifeSciences position peaked at $5.15M in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on General American Investors's 13F filing for Q1 2026, filed 1 May 2026.